Production (Stage)
Enanta Pharmaceuticals, Inc.
ENTA
$7.50
$0.091.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 193.38M | 216.69M | 248.19M | 230.09M | 300.31M |
| Total Receivables | 40.63M | 40.16M | 38.65M | 40.63M | 39.79M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.86M | 10.68M | 12.41M | 15.26M | 10.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 608.00K | 608.00K | 608.00K | -- |
| Total Current Assets | 242.86M | 268.15M | 299.85M | 286.58M | 351.03M |
|
|
|||||
| Total Current Assets | 242.86M | 268.15M | 299.85M | 286.58M | 351.03M |
| Net Property, Plant & Equipment | 76.68M | 77.04M | 73.35M | 66.26M | 58.37M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.46M | 3.45M | 3.45M | 3.47M | 4.16M |
| Total Assets | 322.99M | 348.64M | 376.65M | 398.82M | 413.56M |
|
|
|||||
| Total Accounts Payable | 4.76M | 4.73M | 8.00M | 10.68M | 6.73M |
| Total Accrued Expenses | 8.31M | 10.58M | 13.55M | 12.83M | 10.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 32.88M | 33.75M | 35.99M | 34.73M | 37.25M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 45.95M | 49.05M | 57.54M | 58.23M | 54.61M |
|
|
|||||
| Total Current Liabilities | 45.95M | 49.05M | 57.54M | 58.23M | 54.61M |
| Long-Term Debt | 126.73M | 131.09M | 136.13M | 143.31M | 149.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 56.54M | 56.45M | 53.94M | 48.14M | 43.41M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 243.00K | 235.00K | 231.00K | 227.00K | 224.00K |
| Total Liabilities | 229.46M | 236.83M | 247.84M | 249.91M | 247.44M |
|
|
|||||
| Common Stock & APIC | 461.74M | 457.18M | 451.55M | 443.79M | 438.34M |
| Retained Earnings | -367.97M | -345.33M | -323.04M | -294.22M | -271.56M |
| Treasury Stock & Other | -224.00K | -29.00K | 302.00K | -653.00K | -667.00K |
| Total Common Equity | 93.54M | 111.82M | 128.81M | 148.92M | 166.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 93.54M | 111.82M | 128.81M | 148.92M | 166.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 93.54M | 111.82M | 128.81M | 148.92M | 166.11M |
|
|
|||||